• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人血清骨保护素与核因子κB受体活化因子配体的性别特异性关联及其与骨密度的关系:兰乔贝纳多研究

The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study.

作者信息

Stern Anna, Laughlin Gail A, Bergstrom Jaclyn, Barrett-Connor Elizabeth

机构信息

Department of Family and Preventive Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0607, USA.

出版信息

Eur J Endocrinol. 2007 May;156(5):555-62. doi: 10.1530/EJE-06-0753.

DOI:10.1530/EJE-06-0753
PMID:17468191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2642656/
Abstract

OBJECTIVE

The role of osteoprotegerin (OPG) and its receptor activator of nuclear factor kappaB legend (RANKL) in the regulation of bone in humans remain unclear. We examined the sex-specific associations of serum OPG, RANKL, and their ratio with bone mineral density (BMD) in older adults.

DESIGN

Participants were 681 community-dwelling adults, ages 45-90 years, who had serum OPG and RANKL measured and bone density scans in 1988-1991, with follow-up scans 5 and/or 10 years later.

METHODS

Analyses were sex-specific; women using and not using estrogen were evaluated separately. Cross-sectional analyses used multivariable regression models; longitudinal analyses used repeated measures mixed effects models.

RESULTS

In cross-sectional analyses, age- and weight-adjusted serum OPG levels were significantly positively associated with BMD at the lumbar spine in men, and at the femoral neck, total hip, and lumbar spine in women using estrogen, but not in non-users of estrogen. RANKL concentrations were significantly and inversely associated with BMD in men only, and at the total hip. Neither OPG nor RANKL was significantly associated with bone loss. Results for the RANKL/OPG ratio were the same as those for RANKL alone.

CONCLUSIONS

These results suggest a modulatory effect of both endogenous and exogenous sex hormones on the biologic interaction of OPG, RANKL, and bone.

摘要

目的

骨保护素(OPG)及其核因子κB受体活化因子配体(RANKL)在人体骨骼调节中的作用仍不明确。我们研究了老年人血清OPG、RANKL及其比值与骨密度(BMD)的性别特异性关联。

设计

参与者为681名年龄在45 - 90岁的社区居住成年人,他们在1988 - 1991年测量了血清OPG和RANKL并进行了骨密度扫描,5年和/或10年后进行了随访扫描。

方法

分析按性别进行;分别评估使用和未使用雌激素的女性。横断面分析使用多变量回归模型;纵向分析使用重复测量混合效应模型。

结果

在横断面分析中,年龄和体重调整后的血清OPG水平在男性中与腰椎骨密度显著正相关,在使用雌激素的女性中与股骨颈、全髋和腰椎骨密度显著正相关,但在未使用雌激素的女性中无此关联。RANKL浓度仅在男性中以及在全髋与骨密度显著负相关。OPG和RANKL均与骨质流失无显著关联。RANKL/OPG比值的结果与单独的RANKL相同。

结论

这些结果表明内源性和外源性性激素对OPG、RANKL与骨骼的生物学相互作用具有调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0494/2642656/84fc2dec93a9/nihms22995f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0494/2642656/84fc2dec93a9/nihms22995f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0494/2642656/84fc2dec93a9/nihms22995f1.jpg

相似文献

1
The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study.老年人血清骨保护素与核因子κB受体活化因子配体的性别特异性关联及其与骨密度的关系:兰乔贝纳多研究
Eur J Endocrinol. 2007 May;156(5):555-62. doi: 10.1530/EJE-06-0753.
2
Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.绝经后女性血清核因子-κB 受体活化因子配体、骨保护素、高敏 C 反应蛋白与骨密度之间的关系:骨免疫与骨炎症
Menopause. 2009 Sep-Oct;16(5):950-5. doi: 10.1097/gme.0b013e3181a181b8.
3
Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study.与骨保护素和核因子-κB 配体相关的骨丢失:特罗姆瑟研究。
Osteoporos Int. 2010 Jun;21(6):931-8. doi: 10.1007/s00198-009-1035-6. Epub 2009 Aug 22.
4
Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.中国绝经前后妇女 RANK、RANKL 和 OPG 基因多态性与骨密度的关系。
Clin Biochem. 2013 Oct;46(15):1493-501. doi: 10.1016/j.clinbiochem.2013.03.011. Epub 2013 Mar 24.
5
Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women.健康中国女性中胰岛素样生长因子-I(IGF-I)与骨保护素(OPG)、核因子κB受体活化因子配体(RANKL)及骨密度之间的关系
Osteoporos Int. 2008 Feb;19(2):221-6. doi: 10.1007/s00198-007-0440-y. Epub 2007 Aug 17.
6
Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis.骨保护素和核因子-κB 受体活化因子配体在类风湿关节炎相关性骨质疏松症发病机制中的作用。
Rheumatol Int. 2012 Nov;32(11):3397-403. doi: 10.1007/s00296-011-2175-5. Epub 2011 Nov 6.
7
Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.1型糖尿病儿童和青少年中较高水平的可溶性核因子κB受体活化因子配体(s-RANKL)和骨保护素可能表明破骨细胞信号增加以及骨量降低的易感性:一项多变量横断面分析。
Osteoporos Int. 2016 Apr;27(4):1631-1643. doi: 10.1007/s00198-015-3422-5. Epub 2015 Nov 20.
8
Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus.血清 RANKL、骨保护素(OPG)及 RANKL/OPG 比值与系统性红斑狼疮患儿的相关性研究
Lupus. 2019 Sep;28(10):1233-1242. doi: 10.1177/0961203319867129. Epub 2019 Aug 12.
9
Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.RANK/RANKL/OPG 系统中的基因-基因相互作用影响绝经后妇女的骨密度。
J Steroid Biochem Mol Biol. 2010 Jan;118(1-2):102-6. doi: 10.1016/j.jsbmb.2009.10.013. Epub 2009 Nov 5.
10
Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis.肾结石患者低骨量与血清核因子κB受体活化因子配体(RANKL)及骨保护素(OPG)之间的关联
BMC Nephrol. 2018 Jul 11;19(1):172. doi: 10.1186/s12882-018-0960-z.

引用本文的文献

1
Delayed Bone Age and Osteoprotegerin Levels in Pediatric Celiac Disease: A Three-Year Case-Control Study.儿童乳糜泻的骨龄延迟与骨保护素水平:一项为期三年的病例对照研究
Nutrients. 2025 Jul 11;17(14):2295. doi: 10.3390/nu17142295.
2
The potential calcium content of anchovy on mandibular bone growth through osteoprotegerin expression analysis.通过骨保护素表达分析研究凤尾鱼潜在钙含量对下颌骨生长的影响。
J Oral Maxillofac Pathol. 2024 Jul-Sep;28(3):374-380. doi: 10.4103/jomfp.jomfp_484_23. Epub 2024 Oct 15.
3
Vertebral marrow fat fraction is associated with circulating RANKL in postmenopausal females.

本文引用的文献

1
Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study.老年人肾功能、骨密度、骨质流失和骨质疏松性骨折的测量:兰乔贝纳多研究
J Bone Miner Res. 2007 Feb;22(2):203-10. doi: 10.1359/jbmr.061014.
2
Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.雌激素和睾酮通过不同的细胞途径抑制破骨细胞生成和骨吸收。
J Bone Miner Res. 2005 Dec;20(12):2224-32. doi: 10.1359/JBMR.050803. Epub 2005 Aug 1.
3
Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment.
绝经后女性的椎体骨髓脂肪分数与循环 RANKL 相关。
Front Endocrinol (Lausanne). 2024 Sep 16;15:1442046. doi: 10.3389/fendo.2024.1442046. eCollection 2024.
4
Delineating the relationship between circulating osteoprotegerin and bone health in women with a pathogenic variant in : A cross-sectional analysis.明确携带致病变体的女性循环骨保护素与骨骼健康之间的关系:一项横断面分析。
Bone Rep. 2024 Sep 6;22:101802. doi: 10.1016/j.bonr.2024.101802. eCollection 2024 Sep.
5
Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study.阿拉伯绝经后妇女骨密度与 RANKL 和骨保护素的相关性:一项横断面研究。
Medicina (Kaunas). 2022 Jul 22;58(8):976. doi: 10.3390/medicina58080976.
6
Associations between bone mineral density and subclinical peripheral arterial disease in elderly men with type 2 diabetes mellitus.2 型糖尿病老年男性骨密度与亚临床周围动脉疾病的相关性。
Osteoporos Int. 2022 Aug;33(8):1715-1724. doi: 10.1007/s00198-022-06404-z. Epub 2022 Apr 22.
7
The Short-Term Effect of Prunes in Improving Bone in Men.梅干改善男性骨骼的短期效果。
Nutrients. 2022 Jan 10;14(2):276. doi: 10.3390/nu14020276.
8
Age-related changes and reference intervals of RANKL, OPG, and bone turnover markers in Indian women.印度女性 RANKL、OPG 和骨转换标志物的年龄相关性变化及参考区间。
Arch Osteoporos. 2021 Oct 4;16(1):146. doi: 10.1007/s11657-021-01014-4.
9
A cross-sectional survey of a public, evidence-based multimodal program for cognitive health in older adults.一项针对老年人认知健康的公共循证多模式项目的横断面调查。
Arch Public Health. 2021 Sep 16;79(1):165. doi: 10.1186/s13690-021-00670-9.
10
Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis.雄激素剥夺疗法对血清骨硬化蛋白、Dickkopf-1 和骨保护素水平的影响:一项横断面和纵向分析。
Sci Rep. 2021 Jul 21;11(1):14905. doi: 10.1038/s41598-021-94090-y.
循环骨保护素与核因子κB受体活化因子配体:在代谢性骨病评估中的临床应用
J Clin Endocrinol Metab. 2005 Nov;90(11):6323-31. doi: 10.1210/jc.2005-0794. Epub 2005 Aug 16.
4
Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins.骨保护素和核因子κB受体活化因子配体的循环量:对女性双胞胎的遗传影响及其与骨密度的关系评估
Bone. 2005 Apr;36(4):727-35. doi: 10.1016/j.bone.2004.12.015.
5
Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.血清骨保护素及其与骨密度和骨转换标志物的关系。
Osteoporos Int. 2005 Apr;16(4):417-23. doi: 10.1007/s00198-004-1699-x. Epub 2004 Jul 20.
6
The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women.血清骨保护素对绝经后女性骨量和椎体骨折的影响
Osteoporos Int. 2005 Nov;16(11):1368-74. doi: 10.1007/s00198-005-1844-1. Epub 2005 Feb 12.
7
Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males.循环骨保护素和核因子κB受体活化因子配体系统与中年男性的骨代谢相关。
Clin Endocrinol (Oxf). 2005 Jan;62(1):92-8. doi: 10.1111/j.1365-2265.2004.02179.x.
8
Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells.睾酮可增加小鼠成骨细胞中骨保护素mRNA的表达。
Horm Metab Res. 2004 Oct;36(10):674-8. doi: 10.1055/s-2004-826013.
9
The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women.健康女性循环骨保护素水平与骨矿物质代谢之间的关系。
Clin Endocrinol (Oxf). 2004 Aug;61(2):244-9. doi: 10.1111/j.1365-2265.2004.02090.x.
10
Circulating levels of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin/macrophage-colony stimulating factor in a presumably healthy human population.核因子-κB受体激活剂配体/骨保护素/巨噬细胞集落刺激因子在健康人群中的循环水平。
Eur J Endocrinol. 2004 Mar;150(3):305-11. doi: 10.1530/eje.0.1500305.